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Abstract
One common way to test for diabetes is the Oral Glucose Tolerance
Test or OGTT. Most common methods for the analysis of the data on
this test are wasteful of much of the information contained therein. We
propose to model blood glucose during an OGTT using a compartmental
dynamic model with a system of ODEs. Our model works well in de-
scribing most scenarios that occur during an OGTT considering only 4
parameters. Fitting the model to data is an inverse problem, which is suit-
able for Bayesian inference. Priors are specified and posterior inference
results are shown using real data.
1 Introduction
Type 2 diabetes is a serious and common illness. It typically develops without
obvious symptoms, and can go undiagnosed for years. With timely diagno-
sis and treatment type 2 diabetes can change from a serious and potentially
life threatening illness to a relatively mild condition. Similarly, a patient who
is informed that he or she is at risk of developing type 2 diabetes can often
take appropriate measures and thus prevent diabetes from occurring altogether
(Wild, Roglic, Green, Sicree, and King, 2004; Metzger, 2006).
Diabetes occurs when the body is unable to adequately regulate blood glu-
cose. The body’s main mechanism for reducing blood glucose is insulin, which
is a hormone produced by the pancreas in response to high levels of blood sugar.
Diabetes occurs either because insulin production is insufficient, or because the
insulin being produced is ineffective. In either case, the result is that the body
cannot reduce blood glucose to healthy levels (Metzger, 2006).
For diagnosis of type 2 diabetes, one common test is the Oral Glucose Tol-
erance Test, or OGTT. For this test, a fasting patient arrives and his or her
resting glucose is measured from a blood sample. The patient then drinks
a 75g glucose concentrate and blood glucose is measured repeatedly over the
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course of the next two hours. The exact glucose measuring times vary de-
pending on local practices. The results of these measurements are expected to
provide some notion of how the patient’s body handles the glucose (Jansson,
Lindskog, Norde´n, Carlstro¨m, and Scherste´n, 1980; Davidson, Schriger, Peters,
and Lorber, 2000; Anderwald, Gastaldelli, Tura, Krebs, Promintzer-Schifferl,
Kautzky-Willer, Stadler, DeFronzo, Pacini, and Bischof, 2011).
In practice, the analysis of OGTT tests is usually done using very simple
guidelines. Typically used markers include the average of the observed glucose
measurements and/or the value of the first and last measurement. A patient
is considered diabetic if the measurement chosen is above a certain threshold
(typically 200mg/dl). While this analysis has proven to be useful, it disregards
one of the primary qualities of OGTT test conditions: That they measure the
evolution of a process over time (Davidson et al., 2000).
Accordingly, here we propose a dynamic model based on Ordinary Differ-
ential Equations (ODEs) to model blood glucose during an OGTT. The idea
of using mathematical models to analyze OGTT results is not new. Previously
proposed models have not been used for inference, mostly because they lack
the flexibility to explain many of the phenomena seen in OGTTs. For instance,
Jansson et al. (1980) assumes that the body only ever lowers blood glucose, but
in the course of measuring several patients we can see that this is not always
the case (see real data in section 4.1)
In our approach, we use a dynamic model which was derived from the rec-
ommendations of our medical collaborators and follows the logic of previous
related works such as Palumbo, Ditlevsen, Bertuzzi, and Gaetano (2013). It
is flexible enough to describe most of the observed behavior of glucose in real
patient’s OGTTs. Using Bayesian inference, we put appropriate priors on the
parameters and fit this model to real data. We have been able to achieve good
fits for observed data and our results match the intuition of our medical collab-
orators well enough that we consider it a good candidate to be considered for
serious analysis of OGTT data and eventually for early diasgnosis.
The paper is organized as follows, in section 2 we present the dynamic model.
In section 3 We develop a Bayesian statistical model that can be used to draw
inference from the dynamic model. In section 4 we explain the details of how to
perform inference from the model, and present results of said inference on real
patients. Finally, section 5 concludes the paper.
2 The dynamic model
Our model is based on the interaction of glucose, insulin and glucagon only. The
glucose regulation system is far more complex but in the controlled environment
of an OGTT these are by far the leading factors. Insulin is a hormone secreted
by the pancreas which reduces blood glucose. Glucagon is also a hormone
produced in the pancreas and has the opposite effect, it triggers the liver to
produce glucose, thus increasing blood glucose levels. In simple terms, insulin
is produced when blood glucose is high and glucagon is produced when blood
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Interpretation Value
G Blood glucose. State variable
I Blood Insulin. State variable
L Blood Glucagon. State variable
D Glucose in digestive system. State variable
V Glucose not yet in the digestive system State variable
θ0 Insulin responsiveness Unknown par.
θ1 Glucagon responsiveness Unknown par.
θ2 Glucose digestive system mean life. Unknown par.
a, b Insulin and Glucagon clearance mean life. 31 min.
c Time taken to drink most of the glucose solution 5 min max.
Table 1: Meanings of state variables and parameters in the OGTT model.
glucose is low, to make a feedback system of blood glucose level regulation (Jiang
and Zhang, 2003; Palumbo et al., 2013).
Our dynamical model is represented by the following system of ODEs
dG
dt
= L− I + D
θ2
(1)
dI
dt
= θ0(G−Gb)+ − I
a
(2)
dL
dt
= θ1(Gb −G)+ − L
b
(3)
dD
dt
= −D
θ2
+
2V
c
(4)
dV
dt
= −2V
c
(5)
where the meaning of each of the state variables and parameters is explained in
table 1.
The heuristics behind this model are similar to other glucose-insulin models
(Palumbo et al., 2013, for instance) and are as follows. There is a threshold
level of glucose which the body hopes to maintain which is denoted by Gb. It is
set at 80mg/dl for all examples in this paper, but it can be adjusted or inferred
otherwise if that is deemed appropriate. If blood glucose goes above Gb then
insulin is produced, increasing dIdt as indicated by (2). As insulin is produced,
this acts to reduce glucose concentration in the blood, reducing dGdt as indicated
by (1). The opposite effect is achieved by glucagon, as seen in (3) and (1).
Insulin and glucagon are both metabolized and decrease with mean lifes a and
b as seen in equations (2) and (3), respectively.
D(t) and V (t) represent glucose which is moving into the bloodstream. It
begins outside the body, ie. the sugar concentrate V (t), decreasing and moving
into the digestive system, D(t), as seen in (5) and (4), and then from the
digestive system moving into the bloodstream, as seen in (4) and (1).
3
Time is measured in hours, and blood glucose is measured in mg/dL of
blood. The units of glucagon and insulin are more abstract and can be thought
of in terms of their effect on units of blood glucose. Insulin and glucagon re-
sponsiveness include both the generation of the hormone and also the response
of the body to the hormone after production. The model is not intended for in-
sulin nor glucagon level prediction and only glucose measurements are available,
therefore in our model the units of I and L are not relevant and not directly
interpretable.
a and b are extrapolated from best estimates of insulin and glucagon clear-
ance time from Duckworth, Bennett, and Hamel (1998). Similarly, estimates
exist on times of glucose absorption into the body (Anderwald et al., 2011),
but these vary greatly from patient to patient and thus θ2 is inferred. Jointly
with θ0 and θ1, which are also inferred, these parameters represent the patient’s
condition in our model.
For the examples in this paper, the system of ODEs is solved numerically
(there is no known analytic solution). This is done by using the odeint function
in the scipy package of the python programming language, (Jones, Oliphant,
Peterson, et al., 01 ). This uses an implementation of the LSODA algorithm,
described in Petzold (1983).
While some justification for the dynamic model comes from the heuristics,
this is secondary to the real issue, which is whether its behavior can adequately
represent what happens to glucose inside a patient’s body. In figure 1 we see
glucose curves which follow from the model. The first three curves all start
at Gb, to show the behavior of the model when the patient is already stable.
One of the purposes of asking patients to fast beforehand is precisely to obtain
this behavior – however, particularly for diabetic patients, fasting may not be
sufficient and glucose may begin elsewhere. The curves in the right panel of
figure 1 represent a scenario wherein glucose begins somewhere other than Gb.
3 Statistical model for the OGTT data analysis:
The Inverse Problem
In order to perform inference on the OGTTs of real patients, the model must
be fit to the data, ie. the patient’s glucose readings over the course of the test.
For instance, for one real patient, at times t = 0:00, 0:30, 1:00, 1:30, and 2:00
hours we obtained glucose measurements of y = 81, 156, 141, 102, and 89 mg/dl
respectively. The intent is to use these data to infer the glucose curves. We
assume data to be observations of G(t) at the measured times and model the
data y with
yi = G(ti) + i
where i ∼ N (0, σ2) and σ = 5mg/dl for all examples in this paper. This allows
us to write the likelihood as
f(y|θ) ∝
∏
i
e−
yi−G(ti|θ)
2σ2 .
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Figure 1: Left: Three curves produced by our model, all beginning with
G(0) = Gb = 80mg/dl these represent three kinds of patient: The dotted line
is a healthy normal patient, the broken line is a diabetic patient who does not
adequately regulate insulin, and the solid line is an oscillating patient, whose
insulin and glucagon response is very strong. Right: Curves showing similar
scenarios but with slightly different parameter values, including G(0).
Fitting this kind of model is considered an inverse problem; a non-linear re-
gression problem with a complex regressor defined through a system of ODEs.
These systems are frequently characterized by drastically different sets of pa-
rameters fitting well with the same data, leading to many explanatory scenarios.
For this reason, classical statistical estimators, such as the least squares estima-
tor, only select one possible scenario, often quite an unreasonable one, following
the data closely. There are several ways to address this issue, but one popular
choice is to use Bayesian inference and encode some notion of what reasonable
parameter combinations are in the prior distribution (Fox, Haario, and Christen,
2013; Kaipio and Somersalo, 2006).
For all of the examples in this paper, the following priors were used:
θ0 ∼ Gamma(2, 0.25)
θ1 ∼ Gamma(2, 0.25)
θ2 ∼ Gamma(10, 20)
Gb ∼ N (80, 20000) truncated to [30, 400].
The priors for θ0 and θ1 were chosen to give high probability to all values
estimated from even the most extreme patients that have been analyzed in
this way. The prior for θ2 is chosen to match information in Anderwald et al.
(2011). The prior for Gb is centered on healthy patients and is truncated since
any patient whose initial glucose is outside of this range should not undergo
an OGTT test but instead be placed into emergency care (AM performs a
preliminary finger stick glucose test precisely for this purpose).
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4 Inference
The object of interest is the function G(t) for each patient and inference is per-
formed on data from each patient separately leading to a separate posterior for
θ0, θ1, θ2 and Gb for each patient. Our objective here is not a population study,
and hence we concentrate on studying our model and its ability to fit OGTT
data parsimoniously. Posterior exploration is achieved using MCMC techniques.
Most MCMCs must be tuned to the posterior for each situation and in this case
for each patient. A practical alternative is to use a self-tuning MCMC algo-
rithm. One such algorithm is the t-walk, which is an MCMC algorithm that
adapts to the scale of the target distribution. This is the algorithm that was
chosen for this case, see Christen and Fox (2010).
Posterior exploration can be done in reasonable time even without high end
hardware. All the examples in this paper were performed on a laptop computer
with an i5 processor and took less than 2 minutes to perform 15000 iterations
of the t-walk. This represents 150 pseudo-independent posterior samples (using
higher than necessary autocorrelation times, to account for patients with pos-
terior distributions which are harder to explore than usual). This is quite an
acceptable numerical processing time, since it takes 2 hours to gather the blood
samples and processing is typically done overnight, depending on the availability
of staff and laboratory equipment.
4.1 Results
Figure 2 shows a posterior sample for three real patients. The curves fit the
data well, even for the third patient (top to bottom), whose data would not fit
a curve which does not account for glucagon. The first patient is a healthy pa-
tient, whose body handles glucose normally. The second patient is a potentially
diabetic patient, whose glucose does not return to the baseline during the test.
The third patient is a patient whose body responds rapidly to glucose, causing
oscillations. Performing inference on many patients has shown that the latter
is not an unusual or rare situation.
0 These curves display more nuance than current guidelines or practices for
OGTT analysis. For instance, current practices would not distinguish between
the first and third patients, despite their metabolism showing clearly different
behavior, since the maximum measured value for both patients is similar (note
also that although the first patient has higher glucose measurements, the third
actually achieves a higher peak value in the estimated curve; this information
can only be found by considering the temporal aspect of the measurements).
Our model has strong descriptive power, giving reasonably small uncertainty
for times in the measurement interval. It also has reasonable predictive power
for a short time outside of the measurement interval as can be seen by prolonging
the function G(t) beyond the last measurement (in our graphs we prolong this
an additional hour.) This can be thought of as a projection of what the patient’s
glucose would be if the conditions of the experiment were to continue. It is not
clear, however, how long the dynamics of the system can be expected to remain
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Figure 2: OGTT inference for three patients. The first appears to be a healthy
patient, the second a diabetic and the third an oscillating case. The graphs
show the posterior distribution of G(t) over 3 hours. Each vertical slice is a
kernel density estimate of the posterior distribution of G(t) at that time. The
dots are the collected data.
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θ0 θ1 θ2
Figure 3: Histograms of posterior samples for the first patient. They are the
parameters θ0, θ1, and θ2 respectively. They are superimposed on a graph of the
prior density of each parameter. In particular we note that for θ1 the posterior
matches the prior closely, and for θ0, the data is extremely informative.
θ0 θ1 θ2
Figure 4: Similar graphs for the second (potentially diabetic) patient. Once
again we note that θ1 once again deviates very little from the prior. This is
caused by having no data below Gb.
intact, so this interpretation should only be considered over a short term.
Figures 3, 4 and 5 show histograms obtained from the MCMC posterior
sampling for each of the model parameters for the patients from figure 2. The
priors are represented with solid lines for reference. We may note that for
patients without measurements below their resting glucose levels the data is
uninformative about θ1, which represents glucagon response. This is to be
expected since in our model glucagon does not kick in unless blood glucose goes
below Gb. Oscillating patients do provide data that is informative with regards
to θ1.
θ0 θ1 θ2
Figure 5: Similar graphs for the third (oscillating) patient. We note that in this
case, the data that is below Gb gives us information about θ1.
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5 Conclusions
The diagnosis of type 2 diabetes is an important public health issue, and it
requires a more sophisticated tool than the direct recording of values from the
test, not only because these values are insufficiently informative, also because
they do not account for measurement error.
Our model shows that overall it is able to represent the results of OGTT tests
for nearly all patients for whom a fit was attempted. For one patient for whom
the fit failed, it was later discovered that there was an error when recording the
data, and the failure of the model to fit was an indication that triggered this
error’s discovery. The model also displays significantly deeper nuance and detail
than previous analysis techniques could ever hope to represent.
At present, this model serves for the analysis of OGTT data, but not for
diagnosis. The reason for this is that this model provides much more information
than had previously been available, and our medical collaborators are - as of
yet - uncertain about how to interpret this new information for which they have
not been trained. Further study is required in order to transform full glucose
curves into diagnoses or treatment recommendations. That said, this kind of a
study should be well worth the effort.
At present, there is no known method which serves to diagnose initial stages
of type 2 diabetes quickly, and accurate diagnosis may only be done by follow-
ing a patient over time. Regarding our model, we can envisage a faster and
simpler solution based on a single dimensional marker. One single dimensional
marker that seems reasonable is min {t : G(t) = Gb and G′(t) < 0} (first return
of blood glucose to the base level Gb), although simply using the marginal pos-
terior distribution for θ0, and comparing it with references θ0 values in healthy
patients, might also be a possibility.
We consider this model a strong candidate for further research in the analysis
of OGTT data. However, even if not this specific model, some sort of dynamical
model with strong descriptive power is required for the important and delicate
tasks involved in the analysis of OGTT tests.
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